Antiasthamatic Activity of Betulinic Acid as a Current Bioactive Compound in an Experimental Model

Abstract

aims: The purpose of this study was to assess BA's effectiveness in treating bronchial asthma and to use molecular docking to find BA's binding energy with β-adrenoceptor. background: The natural triterpenoid molecule betulinic acid (BA) has many biological and therapeutic uses, one of which is the relief of asthma symptoms. objective: The purpose of this study was to assess BA's effectiveness in treating bronchial asthma and to use molecular docking to find BA's binding energy with β-adrenoceptor. method: Methods: The extraction technique involved the use of ethanol as a solvent and the herb Bacopa monnieri. Budesenoid was used as a standard drug. AutoDock vina in PyRx 0.8 was used for the molecular docking investigation. An acute toxicity examination was conducted according to OECD guideline 425. A guinea pig model of asthma called anaphylactic microshock was employed to ascertain the antiasthmatic efficacy of the medication under investigation. Antiasthmatic activity was performed by dividing the animals into four groups each containing six animals. Group 1 was the control group received only vehicle. Group 2 was the standard group received budesenoid. Group 3 was the test group received B. monnieri extract. Group 4 was the test group received betulinic acid (BA). result: Results: In terms of binding affinity, BA has a value of -7.45 kcal/mol. In line with earlier findings, molecular docking showed that BA bound to the hydrophobic cavity of LOX-5, and the formation of hydrogen bonds altered the micro-environment and structure of LOX-5. This resulted in a reduction in enzyme activity. The mean pre-convulsion time for Drug-1 was 506.66 in comparison to the control group as observed in guinea pig model of asthma. conclusion: Conclusion: It may be a good analytical approach to test BA or BA derivatives with a stronger antiasthmatic profile with the help of computed properties. BA was found effective in reducing anaphylaxis in animal model, thus, it may be useful against asthma. other: Conclusion: It may be a good analytical approach to test BA or BA derivatives with a stronger antiasthmatic profile with the help of computed properties. BA was found effective in reducing anaphylaxis in animal model, thus, it may be useful against asthma.